OneHealth Solutions is a behavior change platform company that aims to improve health outcomes and the cost of care for patients, providers, payers and employers. The company has experienced significant success thus far, receiving not one, but two Web Health Awards last summer for its Chronic Disease Portal website and OneHealth OnTheGo mobile application.
The company's latest feat is the successful closing of a $9-million series B funding round this week, bringing the total funding raised thus far to $16 million in equity capital.
The round was led by prior investor Lemhi Ventures, a venture capital firm that specializes in healthcare services companies which use innovative products to drive change in healthcare delivery.
Indeed, the OneHealth platform fits that description. Using game mechanics, social networking, peer support communities and clinical protocols, OneHealth helps to engage and empower participants in achieving health goals related to modifiable risks, behavioral health and chronic disease. The HIPAA-compliant platform supports a wide range of chronic behavioral and medical conditions, while offering access to peer health coaches community managers, expert discussions and live online meetings to "drive positive behavior change."
OneHealth Solutions plans to use its newly acquired funds to expand its sales and marketing divisions in order to better take advantage of current business opportunities, while expanding the platform to support more of the total medical and behavioral spend toward chronic conditions that drive the largest costs.
"This additional capital investment by our existing investor team is an exceptional vote of confidence in OneHealth," said Bruce Springer, CEO at OneHealth, in a statement. "The company has benefited significantly from their insight in building healthcare technology companies, and we look forward to continuing to lead the market adoption of behavior change solutions. This latest round of funding will allow us to move rapidly to continue expanding the platform to support additional chronic medical conditions, accelerate revenue growth in our core business, enhance the support for our channel partners and take advantage of new market opportunities.”
Edited by
Braden Becker
